Research at UTGSM

The University of Tennessee Graduate School of Medicine (UTGSM) strives to meet the needs of our community, our region, and our state through healing, education, and discovery. Our discovery mission provides an environment that promotes meaningful clinical and translational research in the areas of therapeutics, diagnostics, effective healthcare delivery and quality improvement that can positively impact patients and enhance the reputations of the UTGSM and University of Tennessee Medical Center both regionally and nationally.

Our core values:

• To foster an innovative learning organization through the leadership of pre-eminent faculty
• To educate medical students, residents and fellows as providers of competent, safe, and compassionate healthcare
• To promote transformative, translational science and clinical research that addresses important unmet needs
• To cultivate physicians to be educational scholars, lifelong learners, and informed consumers of clinical research
• To collaborate with our partners and community towards achieving these goals

Research in the News

Statewide Biomedical and Clinical Research Collaborative Awards Granted
Researchers from the University of Tennessee Health Science Center College of Medicine, Knoxville (UTHSC COM-Knoxville); the University of Tennessee, Knoxville; and the University of Tennessee Health Science Center Office of Research understand the challenges affecting the health and wellness of Tennesseans. A new system-wide collaborative grant program led by UTHSC COM-Knoxville is supporting research and scholarly activities to pursue discoveries addressing health issues across Tennessee and beyond.

UTGSM and UTMC Pioneer Revolutionary Radionuclide Therapies in Cancer Treatment
In a groundbreaking stride toward advancing cancer treatment, the Molecular Imaging and Translational Research Program (MITRP) at the University of Tennessee Graduate School of Medicine (UTGSM) and The University of Tennessee Medical Center (UTMC) are at the forefront of pioneering Radionuclide Therapies. Under the guidance of Dr. Dustin Osborne, PhD, DABSNM, Professor, and Director of the MITRP, Dr. Yitong Fu, MD, Nuclear Medicine Section Chief, and Brett Hines, RT(R), CNMT, Manager of Nuclear Medicine, these novel therapies represent a transformative approach in the fight against cancer.

New Amyloid Imaging Study at UTGSM Paves the Way in Diagnosis and Therapy
In a significant stride toward improving the challenges faced by patients with systemic amyloidosis, the Amyloidosis and Cancer Theranostics Program (ACTP) at the University of Tennessee Graduate School of Medicine (UTGSM), under the direction of Jonathan Wall, PhD, University Distinguished Professor and Assistant Dean of Research embarked on their latest groundbreaking research. The ACTP team initiated the first-in-human study of a novel diagnostic imaging agent for the detection of cardiac amyloidosis at the UT Medical Center, ushering in a new era in amyloid imaging research.

Meet Our Featured Researchers

Michael Karlstad, PhD, Director Trauma & Critical Care Surgery	Deidra Mountain, PhD, Director Vascular Research	Dustin Osborne, PhD, Director Molecular Imaging & Translational Research
Stacy Stephenson, MD, Director Plastic & Reconstructive Surgery	Jonthan Wall, PhD, Director Amyloidosis & Cancer Theranostics	Eric Heidel, PhD Biostatistics
Steve Kennel, PhD Amyloidosis & Cancer Theranostics	Emily Martin, PhD Amyloidosis & Cancer Theranostics	Tom Masi, PhD Plastic & Reconstructive Surgery